Genesis to Pay SEC $21M Penalty to Settle Charges Over Gemini Earn Product

CoinDeskPolicyPublicado em 2024-03-18Última atualização em 2024-03-19

Resumo

The settlement comes days after a New York judge denied motions by Genesis and crypto exchange Gemini to stop the SEC case.

  • Genesis Global Capital will pay $21 million as a civil penalty in a settlement with the SEC that has now been formalized.
  • The SEC will not receive any "portion of the penalty until after payment of all other allowed claims," the regulator said in a statement.

Bankrupt crypto lender Genesis Global Capital has agreed to a final judgment ordering it to pay $21 million to settle charges with the U.S. Securities and Exchange Commission (SEC) for violating securities laws for its role with the now-defunct Gemini Earn program, the SEC announced Tuesday.

The settlement comes days after a New York judge denied motions by Genesis and crypto exchange Gemini to stop the SEC case filed in January 2023 from moving forward. Genesis and two affiliates had filed for bankruptcy shortly after the SEC charges.

In February 2024, Genesis said in court documents it had agreed with the SEC to settle the charges for $21 million, and it appears the deal has now been finalized.

Advertisement
Advertisement

Critically, the SEC will not receive any "portion of the penalty until after payment of all other allowed claims by the bankruptcy court," the announcement said.

“Today’s settlement builds on previous actions to make clear to the marketplace and the investing public that crypto lending platforms and other intermediaries need to comply with our time-tested securities laws," said SEC Chair Gary Gensler in a statement.

Edited by Nikhilesh De.

Leituras Relacionadas

Stock Price Doubles Within the Year, Plummets 20% After Resumption, Baolai Medical's 'Chip Backdoor Listing' Script Ends

On August 10, 2026, BPL (300246.SZ) resumed trading after a nearly week-long suspension and immediately fell by a 20% limit-down. This plunge was triggered by the termination of a planned controlling stake transfer, dashing earlier market speculation. In January 2026, Zhejiang Quwei Zhihe Partnership entered as a significant shareholder, sparking hopes. Investors speculated that its backer, Weigu Information—a specialized "little giant" company in high-reliability solid-state storage chips—might be seeking a backdoor listing through BPL. This "cross-industry restructuring" expectation fueled a strong rally, with BPL's stock price more than doubling in 2026 prior to the halt. However, the deal was called off on August 7, directly causing the sharp sell-off. Underlying BPL's vulnerability is its fundamentally weak business. The company, a medical device firm, is mired in losses, having reported three consecutive years of net losses totaling over 200 million yuan. Its core hemodialysis business is squeezed by government procurement price cuts, while growth in its patient monitor segment has stalled. Furthermore, BPL faces imminent debt pressure with convertible bonds worth approximately 218 million yuan due in September 2026, and its current stock price is far below the conversion price. The failed control transfer may represent a delayed release of negative news, but BPL's core challenges remain: reversing operational losses and addressing its urgent liquidity crisis.

marsbitHá 2h

Stock Price Doubles Within the Year, Plummets 20% After Resumption, Baolai Medical's 'Chip Backdoor Listing' Script Ends

marsbitHá 2h

Trading

Spot
活动图片